CREDIT SUISSE AG/ - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 104 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2021$21,000
-86.4%
12,076
-83.1%
0.00%
Q3 2021$154,000
-36.1%
71,468
+3.8%
0.00%
Q2 2021$241,000
-64.3%
68,860
+0.6%
0.00%
Q1 2021$675,000
-32.7%
68,455
-26.0%
0.00%
Q4 2020$1,003,000
-40.1%
92,492
-43.1%
0.00%
-100.0%
Q3 2020$1,674,000
-19.1%
162,438
+63.9%
0.00%0.0%
Q2 2020$2,070,000
+314.0%
99,110
+93.9%
0.00%
Q1 2020$500,000
-52.8%
51,119
-44.4%
0.00%
-100.0%
Q4 2019$1,060,000
+1506.1%
91,947
+653.8%
0.00%
Q3 2019$66,000
-53.8%
12,197
+1.6%
0.00%
Q2 2019$143,000
+120.0%
12,009
-3.6%
0.00%
Q1 2019$65,000
+58.5%
12,458
-4.0%
0.00%
Q4 2018$41,000
-50.0%
12,974
-16.7%
0.00%
Q2 2018$82,000
+134.3%
15,568
+29.9%
0.00%
Q4 2016$35,000
-41.7%
11,982
-18.2%
0.00%
Q3 2016$60,000
-61.8%
14,647
-70.5%
0.00%
Q2 2016$157,00049,6960.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2019
NameSharesValueWeighting ↓
VHCP Management, LLC 1,102,735$3,485,0003.61%
VHCP Management II, LLC 280,000$885,0000.53%
GREAT POINT PARTNERS LLC 550,116$1,738,0000.50%
JW Asset Management, LLC 189,919$600,0000.48%
DAFNA Capital Management LLC 140,600$444,0000.35%
Granite Point Capital Management, L.P. 186,544$589,0000.25%
SABBY MANAGEMENT, LLC 779,926$2,465,0000.13%
TFS CAPITAL LLC 159,364$504,0000.09%
Rhenman & Partners Asset Management AB 154,006$487,0000.09%
Numeric Investors LLC 1,134,931$3,586,0000.03%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders